Axcend Awarded a Phase II SBIR Grant from the National Institutes of Health
Axcend Awarded a Phase II SBIR Grant from the National Institutes of Health Share Article This Phase II SBIR Grant continues successful Phase I research by Axcend to develop a “Portable Liquid Chromatography Platform for Diverse Pharmaceutical Applications” The Axcend Focus LC, Axcend's hand-portable, lightweight and compact capillary high-performance liquid chromatography (HPLC) system We are honored to receive this Phase II SBIR grant and look forward to successfully developing and commercializing compact HPLC for pharmaceutical applications. PROVO, Utah ...
Source: prweb.com